Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1970 1
1974 1
1975 5
1976 1
1979 1
1982 1
1983 2
1984 1
1985 2
1988 2
1989 1
1990 2
1991 3
1992 1
1995 1
1998 1
2003 1
2005 2
2006 3
2007 3
2008 3
2009 1
2010 3
2011 2
2012 3
2013 5
2014 9
2015 8
2016 13
2017 9
2018 7
2019 5
2020 4
2021 9
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for brain applebaum
Search for Brian Applebaum instead (1 results)
The radiologically isolated syndrome: revised diagnostic criteria.
Lebrun-Frénay C, Okuda DT, Siva A, Landes-Chateau C, Azevedo CJ, Mondot L, Carra-Dallière C, Zephir H, Louapre C, Durand-Dubief F, Le Page E, Bensa C, Ruet A, Ciron J, Laplaud DA, Casez O, Mathey G, de Seze J, Zeydan B, Makhani N, Tutuncu M, Levraut M, Cohen M, Thouvenot E, Pelletier D, Kantarci OH. Lebrun-Frénay C, et al. Brain. 2023 Aug 1;146(8):3431-3443. doi: 10.1093/brain/awad073. Brain. 2023. PMID: 36864688 Free PMC article.
Treatment interventions for pusher syndrome: A case series.
Pardo V, Galen S. Pardo V, et al. NeuroRehabilitation. 2019;44(1):131-140. doi: 10.3233/NRE-182549. NeuroRehabilitation. 2019. PMID: 30814367
BACKGROUND: Pusher syndrome (PS) is a clinical disorder that causes decreased postural balance and active pushing away from the non-hemiparetic side in patients with right or left brain damage. Therapists are challenged by needing to manage both the hemiparetic and the pus …
BACKGROUND: Pusher syndrome (PS) is a clinical disorder that causes decreased postural balance and active pushing away from the non-hemipare …
Dendrimer technologies for brain tumor.
Mishra V, Kesharwani P. Mishra V, et al. Drug Discov Today. 2016 May;21(5):766-78. doi: 10.1016/j.drudis.2016.02.006. Epub 2016 Feb 15. Drug Discov Today. 2016. PMID: 26891979 Review.
Despite low prevalence, brain tumors are one of the most lethal forms of cancer. Unfortunately the blood-brain barrier (BBB), a highly regulated, well coordinated and efficient barrier, checks the permeation of most of the drugs across it. ...Surface-engineered dend …
Despite low prevalence, brain tumors are one of the most lethal forms of cancer. Unfortunately the blood-brain barrier (BBB), …
Dendrimer-mediated approaches for the treatment of brain tumor.
Dwivedi N, Shah J, Mishra V, Mohd Amin MC, Iyer AK, Tekade RK, Kesharwani P. Dwivedi N, et al. J Biomater Sci Polym Ed. 2016;27(7):557-80. doi: 10.1080/09205063.2015.1133155. Epub 2016 Feb 29. J Biomater Sci Polym Ed. 2016. PMID: 26928261 Review.
Worldwide, the cancer appeared as one of the most leading cause of morbidity and mortality. Among the various cancer types, brain tumors are most life threatening with low survival rate. Every year approximately 238,000 new cases of brain and other central nervous s …
Worldwide, the cancer appeared as one of the most leading cause of morbidity and mortality. Among the various cancer types, brain tum …
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Existential distress among caregivers of patients with brain tumors: a review of the literature.
Applebaum AJ, Kryza-Lacombe M, Buthorn J, DeRosa A, Corner G, Diamond EL. Applebaum AJ, et al. Neurooncol Pract. 2016 Dec;3(4):232-244. doi: 10.1093/nop/npv060. Epub 2015 Dec 8. Neurooncol Pract. 2016. PMID: 31385976 Free PMC article. Review.
Studies that examined any element of existential distress among informal caregivers of patients with brain tumors were included. A final sample of 35 articles was reviewed. ...More candid communication between health care providers and caregivers about brain tumor p …
Studies that examined any element of existential distress among informal caregivers of patients with brain tumors were included. A fi …
Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S, Tatiparti K, Sau S, Iyer AK. Reddy S, et al. Drug Discov Today. 2021 Aug;26(8):1944-1952. doi: 10.1016/j.drudis.2021.04.008. Epub 2021 Apr 16. Drug Discov Today. 2021. PMID: 33865978 Review.
Gliomas constitute about 80% of brain tumors and have a meager two-year survival rate. The treatment options available are very few because of poor prognosis and a lack of targeted nanodelivery systems that can cross the blood-brain barrier (BBB) and the blood-tumor …
Gliomas constitute about 80% of brain tumors and have a meager two-year survival rate. The treatment options available are very few b …
Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas.
Koneru T, McCord E, Pawar S, Tatiparti K, Sau S, Iyer AK. Koneru T, et al. ACS Omega. 2021 Mar 22;6(13):8727-8733. doi: 10.1021/acsomega.0c05848. eCollection 2021 Apr 6. ACS Omega. 2021. PMID: 33842744 Free PMC article. Review.
Gliomas constitute 80% of malignant brain tumors. The survival rate of patients diagnosed with malignant gliomas is only 34.4%, as seen in both adults as well as children. The biggest challenge in treatment of gliomas is the impenetrable blood-brain barrier. With th …
Gliomas constitute 80% of malignant brain tumors. The survival rate of patients diagnosed with malignant gliomas is only 34.4%, as se …
113 results